| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0028-3908(86)90207-8 |
| P698 | PubMed publication ID | 2875415 |
| P2093 | author name string | Middlemiss DN | |
| Humphrey PP | |||
| Saxena PR | |||
| Mylecharane EJ | |||
| Feniuk W | |||
| Richardson BP | |||
| Fozard JR | |||
| Engel G | |||
| Bradley PB | |||
| P433 | issue | 6 | |
| P1104 | number of pages | 14 | |
| P304 | page(s) | 563-576 | |
| P577 | publication date | 1986-06-01 | |
| P1433 | published in | Neuropharmacology | Q15332439 |
| P1476 | title | Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine | |
| P478 | volume | 25 |
| Q44543018 | "5-HT1R" or 5-HT1D sites? Evidence for 5-HT1D binding sites in rabbit brain |
| Q48720103 | 3HRauwolscine behaves as an agonist for the 5-HTa receptors in human frontal cortex membranes |
| Q37748457 | 5-HT in migraine--an introduction |
| Q48559630 | 5-HT inhibits lateral entorhinal cortical neurons of the rat in vitro by activation of potassium channel-coupled 5-HT1A receptors. |
| Q41533296 | 5-HT receptor classification and nomenclature: towards a harmonization with the human genome |
| Q37295090 | 5-HT receptors: subtypes and second messengers |
| Q43964308 | 5-HT(2A) receptors: location and functional analysis in intestines of wild-type and 5-HT(2A) knockout mice |
| Q33856568 | 5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review |
| Q36418782 | 5-HT(3) receptors |
| Q54005197 | 5-HT1-like and 5-HT2A receptors mediate 5-hydroxytryptamine-induced contraction of rabbit isolated mesenteric artery. |
| Q35117653 | 5-HT1-like receptor agonists and the pathophysiology of migraine |
| Q42560350 | 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of guinea-pig isolated iliac artery |
| Q35756200 | 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery |
| Q67868439 | 5-HT1-like receptors mediate potentiation of cholinergic nerve-mediated contraction of isolated mouse trachea |
| Q33462273 | 5-HT1-like receptors requiring functional cyclo-oxygenase and 5-HT2 receptors independent of cyclo-oxygenase mediate contraction of the human umbilical artery |
| Q48767098 | 5-HT1-like receptors: a time to bid goodbye |
| Q48548168 | 5-HT1A receptors activate a potassium conductance in rat ventromedial hypothalamic neurones |
| Q60711586 | 5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus |
| Q42048113 | 5-HT1D binding sites in porcine brain can be sub-divided by GR43175. |
| Q60711577 | 5-HT1D receptors in guinea-pig and pigeon brain. Radioligand binding and biochemical studies |
| Q48654791 | 5-HT2 presynaptic receptors mediate inhibition of glutamate release from cerebellar mossy fibre terminals |
| Q28282073 | 5-HT2 receptor antagonists and migraine therapy |
| Q35873605 | 5-HT3 and 5-HT4 receptor-mediated facilitation of the emptying phase of the peristaltic reflex in the marmoset isolated ileum |
| Q42920799 | 5-HT3 antagonists reduce morphine self-administration in rats |
| Q37748465 | 5-HT3 receptor antagonists and migraine therapy |
| Q36711373 | 5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis |
| Q39294002 | 5-HT3 receptors: A potential therapeutic target for epilepsy |
| Q36330074 | 5-HT4 receptor mediated facilitation of the emptying phase of the peristaltic reflex in the guinea-pig isolated ileum |
| Q36470200 | 5-HT4-like receptors in mammalian atria |
| Q48548229 | 5-HTIC receptors mediate phosphoinositide turnover activation in the immature rat hippocampus |
| Q40571185 | 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives |
| Q35871228 | 5-Hydroxytryptamine (5-HT) mediates potent relaxation in the sheep isolated pulmonary vein via activation of 5-HT4 receptors |
| Q70957609 | 5-Hydroxytryptamine 5-HT1D receptors mediating inhibition of cyclic AMP accumulation in Madin-Darby canine kidney (MDCK) cells |
| Q51748240 | 5-Hydroxytryptamine acts at 5-HT2 receptors to decrease potassium conductance in rat nucleus accumbens neurones. |
| Q42721758 | 5-Hydroxytryptamine receptor assays |
| Q40578203 | 5-Hydroxytryptamine receptor subtypes: molecular and functional diversity. |
| Q51725023 | 5-Hydroxytryptamine responses in neonate rat motoneurones in vitro. |
| Q48127047 | 5-Hydroxytryptamine stimulates two distinct adenylate cyclase activities in rat brain: high-affinity activation is related to a 5-HT1 subtype different from 5-HT1A, 5-HT1B, and 5-HT1C |
| Q68048853 | 5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins |
| Q47919641 | 5-Hydroxytryptamine-induced secretion by rat jejunum in-vitro involves several 5-hydroxytryptamine receptor subtypes |
| Q42849285 | 5-Hydroxytryptamine-induced tachycardia in the pig: possible involvement of a new type of 5-hydroxytryptamine receptor |
| Q72864360 | 5-Hydroxytryptamine2 and 5-hydroxytryptamine3 receptors mediate serotonin-induced short-circuit current in pig jejunum |
| Q67959203 | 5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae |
| Q46461776 | 5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes |
| Q41824586 | 5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor |
| Q35888773 | 5-hydroxytryptamine-stimulated accumulation of 1,2-diacylglycerol in the rabbit basilar artery: a role for protein kinase C in smooth muscle contraction |
| Q40601511 | 5HT drugs in animal models of anxiety |
| Q52248872 | 5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward. |
| Q72067440 | 5‐Hydroxytryptamine Receptors |
| Q43550374 | 8-Hydroxy-2-(DI-N-propylamino)tetralin increases the activity of adenylate cyclase in the hippocampus of freely-moving rats |
| Q43521690 | 8-OH-DPAT specifically enhances feeding behaviour in mice: evidence from behavioural competition |
| Q42848081 | 8-OH-DPAT, flesinoxan and guanfacine: systemic and regional haemodynamic effects of centrally acting antihypertensive agents in anaesthetized rabbits |
| Q41783668 | A 5-HT1-like receptor mediates a pertussis toxin-sensitive inhibition of rat ventromedial hypothalamic neurones in vitro |
| Q35888122 | A 5-hydroxytryptamine receptor in human atrium |
| Q44706876 | A Cerebral Endogenous Factor Regulates the Activity of the Serotonergic Receptors Modulating the Neuronal Release of Acetylcholine |
| Q57161235 | A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research |
| Q41952998 | A comparison of fast and slow depolarizations evoked by 5-HT in guinea-pig coeliac ganglion cells in vitro |
| Q24564857 | A human serotonin 1D receptor variant (5HT1D beta) encoded by an intronless gene on chromosome 6 |
| Q33921663 | A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes |
| Q42492966 | A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response |
| Q71874333 | A pharmacological comparison of [3H]-granisetron binding sites in brain and peripheral tissues of the mouse |
| Q35851456 | A review and reevaluation of the role of serotonin in the modulation of lordosis behavior in the female rat |
| Q28142963 | A review of central 5-HT receptors and their function |
| Q33145280 | A review of pathophysiology and therapy of patients with vasovagal syncope |
| Q39164871 | A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment |
| Q59480099 | A short synthesis of cisapride: a gastrointestinal stimulant derived from cis-4-amino-3-methoxypiperidine |
| Q48186555 | A thermodynamic study of 5-[3H]hydroxytryptamine binding to human cortex membranes |
| Q73626998 | Acceleration of gastrointestinal transit by momordin Ic in mice: possible involvement of 5-hydroxytryptamine, 5-HT(2) receptors and prostaglandins |
| Q42563172 | Actions of 5-HT1 ligands on excitatory synaptic transmission in the hippocampus of alert rats |
| Q51187416 | Actions of buspirone in a putative model of anxiety in the mouse. |
| Q55484075 | Activation and desensitization of the 5-HT3 receptor in a rat glioma x mouse neuroblastoma hybrid cell |
| Q46743181 | Activation of a myenteric 5-hydroxytryptamine-like receptor by metoclopramide |
| Q46372411 | Agonist action of indole derivatives at 5-HT1-like, 5-HT3, and 5HT4 receptors in vitro |
| Q59201453 | Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cells |
| Q40918717 | Altered serotonergic activity in women with dysphoric premenstrual syndromes |
| Q42004115 | An endothelial 5-HT receptor that mediates relaxation in guinea-pig isolated jugular vein resembles the 5-HT1D subtype |
| Q42369280 | An enhancing effect of 5-hydroxytryptamine on electrically evoked atropine-resistant contraction of guinea-pig proximal colon |
| Q42025632 | An examination of the 5-HT3 receptor mediating contraction and evoked [3H]-acetylcholine release in the guinea-pig ileum |
| Q60054753 | An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats |
| Q46775335 | Analysis of neurogenic contractions induced by ML-1035 and other benzamides in the guinea-pig non-stimulated isolated ileum |
| Q42167283 | Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery |
| Q72113854 | Antagonistic activities of N-3389, a newly synthetized diazabicyclo derivative, at 5-HT3 and 5-HT4 receptors |
| Q28285299 | Anti-5-hydroxytryptamine3 effect of galanolactone, diterpenoid isolated from ginger |
| Q40493277 | Antiemetic therapy in adults with terminal disease: A brief review |
| Q37039597 | Antiemetics: an update and the MASCC guidelines applied in clinical practice |
| Q44192019 | Antinociceptive effect of ketanserin in mice: involvement of supraspinal 5-HT2 receptors in nociceptive transmission |
| Q48687581 | Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol |
| Q70674114 | Autoradiographic mapping of 5-HT1 receptors in the guinea-pig brain with particular reference to the 5-HT1D receptor sites |
| Q34498523 | Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in braina |
| Q36812148 | Bacterially expressed human serotonin receptor 3A is functionally reconstituted in proteoliposomes |
| Q42563347 | Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors |
| Q35942094 | Behavioural pharmacology of 5-HT3 receptor ligands |
| Q48468698 | Behavioural phenotyping of sodium-myo-inositol cotransporter heterozygous knockout mice with reduced brain inositol |
| Q72058891 | Binding thermodynamics of serotonin to rat-brain 5-HT1a, 5HT2a and 5-HT3 receptors |
| Q39469126 | Biochemical hypotheses on antidepressant drugs: a guide for clinicians or a toy for pharmacologists? |
| Q37111899 | Biological basis of suicide and suicidal behavior |
| Q49044196 | Block by 5-hydroxytryptamine of neuronal acetylcholine receptor channels expressed in Xenopus oocytes |
| Q52242866 | Blockade of acquisition of drug-conditioned place aversion by 5HT3 antagonists. |
| Q42070995 | Canine renovascular responses to sumatriptan and 5-carboxamidotryptamine: modulation through endothelial 5-HT1-like receptors by endogenous nitric oxide |
| Q36912182 | Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications. |
| Q51664745 | Cardiovascular stability with rapid intravenous infusion of ondansetron. |
| Q42848325 | Carotid haemodynamics in pigs during infusions of 8-OH-DPAT: reduction in arteriovenous shunting is mediated by 5-HT1-like receptors |
| Q42112196 | Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors |
| Q24681849 | Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus |
| Q35942133 | Centrally active 5-HT receptor agonists and antagonists |
| Q44445237 | Changes in brain serotonin turnover, body and head shakes in kainic acid-treated rats |
| Q55060710 | Characterisation of 5-HT3 recognition sites in membranes of NG 108-15 neuroblastoma-glioma cells with [3H]ICS 205-930. |
| Q41689855 | Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding |
| Q60733596 | Characterization of 5-HT receptors mediating contraction and relaxation of the longitudinal muscle of guinea-pig distal colon in vitro |
| Q35756243 | Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist |
| Q42562526 | Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro |
| Q41899396 | Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats |
| Q35874518 | Characterization of 5-hydroxytryptamine receptors mediating mucosal secretion in guinea-pig ileum. |
| Q46819174 | Characterization of [3H]quipazine binding to 5-hydroxytryptamine3 receptors in rat brain membranes |
| Q69792720 | Characterization of an endothelial 5-hydroxytryptamine (5-HT) receptor mediating relaxation of the porcine coronary artery |
| Q35755042 | Characterization of presynaptic 5-HT receptors on adrenergic nerves supplying the bovine ovarian follicle |
| Q41951815 | Characterization of rat platelet serotonin receptors with tryptamine agonists and the antagonists: Ketanserin and SCH 23390 |
| Q41858476 | Characterization of the 5-HT receptor mediating endothelium-dependent relaxation in porcine vena cava |
| Q33322577 | Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats |
| Q42920614 | Characterization of the 5-hydroxytryptamine receptor mediating the positive inotropic response in guinea-pig isolated left atria |
| Q48427751 | Characterization of the 5-hydroxytryptamine receptor modulating the release of 5-[3H]hydroxytryptamine in slices of the human neocortex |
| Q35029223 | Characterization of the 5-hydroxytryptamine receptors mediating contraction in the intestine of Suncus murinus. |
| Q49124973 | Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities |
| Q42716106 | Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbens |
| Q68462593 | Chronic administration of the 5-HT3 receptor antagonist BRL 43694; effects on reflex epilepsy and social behaviour of the Mongolian gerbil |
| Q73608228 | Chronotropic action of 5-hydroxytryptamine (5-HT) on colonic migrating motor complexes (CMMCs) in the isolated mouse colon |
| Q24313646 | Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase |
| Q28379115 | Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b) |
| Q54399424 | Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines. |
| Q48587393 | Compared effects of serotonin on cervical and hypoglossal inspiratory activities: an in vitro study in the newborn rat |
| Q42201015 | Comparison between the cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) and clonidine in the conscious sino-aortic denervated rat. |
| Q42197935 | Comparison of [125I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue |
| Q36330430 | Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619 |
| Q69792718 | Comparison of the effects of cromakalim, a potassium conductance enhancer, and nimodipine, a calcium antagonist, on 5-hydroxytryptamine responses in a variety of vascular smooth muscle preparations |
| Q54152275 | Comparison of the intestinal secretory response to 5-hydroxytryptamine in the rat jejunum and ileum in-vitro. |
| Q45188370 | Competitive interaction of agonists and antagonists with 5-HT3 recognition sites in membranes of neuroblastoma cells labelled with [3H]ICS 205-930. |
| Q35888605 | Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites |
| Q68273647 | Contractile effects of 8-hydroxy-2-(di-n-propylamino) tetralin and flesinoxan in human isolated basilar artery |
| Q37084146 | Controlling emesis related to cancer therapy |
| Q39471586 | Controlling the carcinoid syndrome |
| Q77349995 | Crucial role for 5-HT in cholera toxin but not Escherichia coli heat-labile enterotoxin-intestinal secretion in rats |
| Q47744297 | Crucial role of the 5-HT2C receptor, but not of the 5-HT2A receptor, in the down regulation of stimulated dopamine release produced by pressure exposure in freely moving rats |
| Q28326742 | D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse |
| Q46366793 | Decreased 5-HT1A receptor gene expression and 5-HT1A receptor protein in the cerebral cortex and brain stem during pancreatic regeneration in rats |
| Q28270673 | Detection of a novel serotonin receptor subtype (5-HT1E) in human brain: interaction with a GTP-binding protein |
| Q41651437 | Dibutyryl‐cAMP increases functions of 5‐hydroxytryptamine2 receptors, but not of β2‐adrenergic receptors, in a clonal cell line of rat neurotumor RT4 |
| Q42214736 | Differences in agonist dissociation constant estimates for 5-HT at 5-HT2-receptors: a problem of acute desensitization? |
| Q46417154 | Different receptor subtypes mediate the dual presynaptic effects of 5-hydroxytryptamine on peripheral sympathetic neurones |
| Q69358808 | Different regulation of serotonin receptors following adrenal hormone imbalance in the rat hippocampus and hypothalamus |
| Q48794842 | Differential behavioural activation following intra-raphe infusion of 5-HT1A receptor agonists |
| Q41784090 | Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues |
| Q43904349 | Differential subcellular localization of the 5-HT3-As receptor subunit in the rat central nervous system |
| Q37199155 | Direct subunit-dependent multimodal 5-hydroxytryptamine3 receptor antagonism by methadone |
| Q33583271 | Dual effects of serotonin on a voltage-gated conductance in lymphocytes |
| Q51714802 | Effect of (±)-DOI on neuromuscular transmission: a microelectrode study |
| Q51716553 | Effect of 5-hydroxytryptamine and its antagonists on colonic smooth muscle of the rabbit. |
| Q41820121 | Effect of 5-hydroxytryptamine on [3H]-acetylcholine release from guinea-pig striatal slices |
| Q54271818 | Effect of Sumatriptan, a Selective 5-HT1-like Receptor Agonist, on Pial Vessel Diameter in Anaesthetised Cats |
| Q35101377 | Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia |
| Q72071229 | Effect of putative carcinoid mediators on gastric and small bowel transit in rats and the role of 5‐HT receptors |
| Q51619066 | Effect of selective 5HT3 antagonist (GR 38032F) on small intestinal transit and release of gastrointestinal peptides. |
| Q34166451 | Effect of the selective 5-HT3 receptor antagonists ICS 205-930 and MDL 72222 on 5-HTP-induced head shaking and behavioral symptoms induced by 5-methoxy-N,N,dimethyltryptamine in rats: comparison with some other 5-HT receptor antagonists |
| Q42253035 | Effect of the thromboxane A2-mimetic U46619 on 5-HT1-like and 5-HT2 receptor-mediated contraction of the rabbit isolated femoral artery |
| Q42208682 | Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors |
| Q35888097 | Effects of 5-HT3 receptor antagonists on 5-HT and nicotinic depolarizations in guinea-pig submucosal neurones |
| Q42128652 | Effects of 5-hydroxytryptamine agonists and antagonists on the responses of rat spinal motoneurones to raphe obscurus stimulation |
| Q68749126 | Effects of 5-hydroxytryptamine on the firing rates of neurons of the lateral vestibular nucleus in the rat |
| Q42507742 | Effects of 6-hydroxydopamine on pre- and post-junctional 5-HT1-like receptor-mediated responses in dog saphenous vein |
| Q48323692 | Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: evidence for the presence of "5-hydroxytryptamine1-like" receptors |
| Q74341891 | Effects of SL 65.0472, a novel 5-HT receptor antagonist, on 5-HT receptor mediated vascular contraction |
| Q48856433 | Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze |
| Q41786061 | Effects of capsaicin and 5-HT3 antagonists on 5-hydroxytryptamine-evoked release of calcitonin gene-related peptide in the guinea-pig heart |
| Q43559808 | Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding |
| Q42543676 | Effects of ondansetron administration on opioid withdrawal syndrome observed in rats |
| Q67549693 | Effects of serotonergic agonists and antagonists on ganglion cells in the goldfish retina |
| Q67487059 | Effects of serotonin and cAMP on calcium currents in different neurones of Helix pomatia |
| Q40519752 | Effects of serotonin on airways: recent developments |
| Q34377025 | Effects of serotonin on rat ileocolonic transit and fluid transfer in vivo: possible mechanisms of action |
| Q67545784 | Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations |
| Q50886947 | Effects of tachykinins and selective tachykinin receptor agonists on vascular permeability in the rat lower urinary tract: evidence for the involvement of NK-1 receptors. |
| Q54390913 | Electrophysiological characterization of functionally distinct 5-hydroxytryptamine receptors on guinea-pig submucous plexus |
| Q37828705 | Electrophysiology of the central serotonin system: receptor subtypes and transducer mechanisms. |
| Q30436579 | Elimination of ascorbic acid-induced membrane lipid peroxidation and serotonin receptor loss by Trolox-C, a water soluble analogue of vitamin E |
| Q50783085 | Endothelium-dependent relaxation of porcine pulmonary arteries via 5-HT1C-like receptors. |
| Q68243286 | Enhancement of antithrombotic effect of aspirin by metoclopramide in rats |
| Q50966263 | Evaluation of anticonvulsant and nootropic effect of ondansetron in mice. |
| Q42235624 | Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery |
| Q41841277 | Evidence for a 5-HT(1)-like receptor mediating the amplifying action of 5-HT in the rabbit ear artery |
| Q68495441 | Evidence for a direct and non-receptor-mediated action of 5HT2 antagonists on transmembrane cation transport systems |
| Q42849006 | Evidence for depressant 5-HT1-like receptors on rat brainstem neurones |
| Q42233747 | Evidence for excitatory 5-HT2-receptors on rat brainstem neurones |
| Q69003550 | Evidence for inhibition by ICS 205-930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle |
| Q44127643 | Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorenate and ipsapirone. |
| Q35888222 | Evidence for the presynaptic action of 5-hydroxytryptamine and the involvement of purinergic innervation in the rabbit lower urinary tract |
| Q34392331 | Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter |
| Q48851101 | Evidence suggesting that the 5-HT2 antagonist ICI 169,369 activates vagal afferents and in addition has a central hypotensive action in anaesthetized rats |
| Q41159971 | Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis |
| Q45253049 | Evidence that blockade of post-synaptic 5-HT1 receptors elicits feeding in satiated rats |
| Q69202649 | Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors |
| Q24681893 | Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors |
| Q42272631 | Evidence that the 5-HT3 receptors of the rat, mouse and guinea-pig superior cervical ganglion may be different |
| Q42560545 | Evidence that the unilateral activation of 5-HT1D receptors in the substantia nigra of the guinea-pig elicits contralateral rotation |
| Q51763988 | Examination of the effects of some 5-HT2 receptor antagonists on central sympathetic outflow and blood pressure in anaesthetised cats. |
| Q44731614 | Excitatory and inhibitory actions of intrathecally administered 5-hydroxytryptamine on sympathetic nerve activity in the rat |
| Q71658402 | Facilitation by 5-hydroxytryptamine of ATP-activated current in rat pheochromocytoma cells |
| Q41000243 | Factors to consider in the naming of a G protein-coupled receptor subtype |
| Q35233143 | From serotonin receptor classification to the antimigraine drug sumatriptan |
| Q72391654 | Functional 5-HT receptor subtypes in the isolated canine common carotid artery |
| Q41622739 | Functional characteristics of heterologously expressed 5-HT receptors |
| Q34172554 | Functional correlates of serotonin 5-HT1 recognition sites |
| Q45081470 | Functional properties of cells in rat trigeminal subnucleus interpolaris following local serotonergic deafferentation |
| Q41265940 | Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat. |
| Q42084666 | Further characterization of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava |
| Q35755724 | GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein |
| Q36711574 | Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic |
| Q70662873 | Heterogeneity of 5-HT receptor subtypes in isolated human femoral and saphenous veins |
| Q45384865 | How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors |
| Q35893589 | Human Tear Serotonin Levels Correlate with Symptoms and Signs of Dry Eye |
| Q40740599 | Hyperthermia induced by m-trifluoromethylphenylpiperazine (TFMPP) or m-chlorophenylpiperazine (m-CPP) in heat-adapted rats |
| Q55059985 | Identification and characterisation of 5-hydroxytryptamine 3 recognition sites in human brain tissue. |
| Q35870746 | Identification and distribution of 5-HT3 recognition sites in the rat gastrointestinal tract |
| Q45086791 | Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride |
| Q68051956 | Identification of presynaptic 5-HT1 autoreceptors in pig brain cortex synaptosomes and slices |
| Q46662056 | Identification of putative 5-HT4 receptors in guinea-pig ascending colon |
| Q42218643 | Identification of the 5-HT1A receptor binding subunit in rat brain membranes using the photoaffinity probe [3H]8-methoxy-2-[N-n-propyl, N-3-(2-nitro-4-azidophenyl)aminopropyl]aminotetralin |
| Q48645811 | Improvement of 5-HT3 Receptor Binding Assay: Enhancement of Specific [3H]Quipazine Binding with Triton X-100-Treated Membranes from Rat Cortex |
| Q67895386 | In vitro release and tissue levels of ileal serotonin after cisplatin-induced emesis in the cat |
| Q45136767 | In vivo characterization of serotonin receptors on hand vein |
| Q42850031 | Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924. |
| Q35888694 | Influence of acute and chronic chlorimipramine treatment on the 5-HT receptor-mediated modulation of acetylcholine release from the cerebral cortex of freely moving guinea-pigs |
| Q28342316 | Influence of the endothelium on contractile effects of 5-hydroxytryptamine and selective 5-HT agonists in canine basilar artery |
| Q72462298 | Inhibition and sex specific induction of spawning by serotonergic ligands in the zebra mussel Dreissena polymorpha (Pallas) |
| Q69378262 | Inhibition of N-methyl-D-aspartate (NMDA)- and L-glutamate-induced noradrenaline and acetylcholine release in the rat brain by ethanol |
| Q41321643 | Inhibition of cholera toxin-induced intestinal secretion by the 5-HT3 receptor antagonist ICS 205-930. |
| Q68626680 | Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT 1D subtype |
| Q69453513 | Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava |
| Q35871144 | Inhibition of reflex responses of neonate rat lumbar spinal cord by 5-hydroxytryptamine |
| Q69617767 | Inhibition of the 5-HT-induced cardiogenic hypertensive chemoreflex by the selective 5-HT3 receptor antagonist ICS 205-930 |
| Q42562457 | Inhibitory effect of 5-hydroxytryptamine on penile erectile function in the rat. |
| Q46776543 | Interaction analysis between 5-HTTLPR and TNFA -238/-308 polymorphisms in schizophrenia. |
| Q34560840 | Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain |
| Q51752937 | Interactions of the ulcerogen cysteamine with enteric inhibitory nerves and putative transmitters in the rat small intestine. |
| Q35871570 | Investigation into the 5-hydroxytryptamine receptor mediating smooth muscle relaxation in the rat oesophagus |
| Q46635611 | Investigation of the 5-HT receptor mediating relaxation in guinea-pig proximal colon |
| Q42154639 | Investigation of the 5-hydroxytryptamine receptor mechanism mediating the short-circuit current response in rat colon |
| Q35870853 | Investigation of the 5-hydroxytryptamine receptor mediating the 'maintained' short-circuit current response in guinea-pig ileal mucosa |
| Q42564156 | Investigation of the mechanism(s) of 8-OH-DPAT-mediated inhibition of plasma insulin in spontaneously hypertensive rats |
| Q68352819 | Investigations of cardiovascular 5-hydroxytryptamine receptor subtypes in the rat |
| Q73042435 | Involvement of 5-hydroxytryptamine (5-HT)3 receptor mechanisms in regulation of basal pancreatic secretion in conscious rats |
| Q52208170 | Involvement of Serotonin in Developmental Plasticity of Kitten Visual Cortex |
| Q35874258 | Involvement of neurokinins in the non-cholinergic response to activation of 5-HT3 and 5-HT4 receptors in guinea-pig ileum |
| Q36577063 | Ion conductances affected by 5-HT receptor subtypes in mammalian neurons |
| Q48821298 | K+ channel and 5-hydroxytryptamine1A autoreceptor interactions in the rat dorsal raphe nucleus: Anin vitro electrophysiological study |
| Q33159129 | Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease |
| Q45074590 | Kinetics of the membrane current mediated by serotonin 5-HT3 receptors in cultured mouse neuroblastoma cells |
| Q46023038 | Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197. |
| Q44758355 | Lack of antinociceptive activity of sumatriptan in rodents |
| Q42148759 | Mechanism of gastrointestinal abnormal motor activity induced by cisplatin in conscious dogs |
| Q42015479 | Mediation by 5-HT1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries |
| Q48478150 | Metitepine distinguishes two receptors mediating inhibition of [3H]-5-hydroxytryptamine release in guinea pig hippocampus |
| Q41671906 | Migraine to the Year 2000 |
| Q72918906 | Modulation of serotonin binding sites in the brain of the Djungarian hamster, Phodopus sungorus, during adaptation to a short photoperiod |
| Q36849659 | Molecular cloning and functional expression of a serotonin receptor from Caenorhabditis elegans |
| Q24314307 | Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype |
| Q28343925 | Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptor |
| Q35042842 | Molecular cloning, sequence analysis and pharmacological properties of the porcine 5-HT(1D) receptor |
| Q47933284 | Molecular interactions between general anesthetics and the 5HT2B receptor. |
| Q55060387 | Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. |
| Q37828699 | Molecular studies of 5-HT receptors |
| Q28206145 | Molecular, pharmacological and functional diversity of 5-HT receptors |
| Q35756875 | Myenteric 5-HT-containing neurones activate the descending cholinergic excitatory pathway to the circular muscle of guinea-pig ileum |
| Q35007814 | Neurochemical profile of eltoprazine |
| Q34088863 | Neurochemistry and neuropharmacology of emesis - the role of serotonin |
| Q34657732 | Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity |
| Q41878532 | Neuronal involvement in type 1 hypersensitivity reactions in gut epithelia |
| Q36364408 | Neuropharmacology of 5-hydroxytryptamine |
| Q35606492 | Neuropharmacology of emesis in relation to clinical response |
| Q54281464 | New Awakening in Anaesthesia— at a Price |
| Q34175396 | New insights in insurmountable antagonism |
| Q35871091 | Nitric oxide is involved in 5-HT-induced relaxations of the guinea-pig colon ascendens in vitro |
| Q77904056 | Nitrogen-containing heteroalicycles with serotonin receptor binding affinity: development of gastroprokinetic and antiemetic agents |
| Q68061829 | No alterations in the 5-HT1A-mediated inhibition of forskolin-stimulated adenylate cyclase activity in the hippocampal membranes from rats chronically treated with lithium or antidepressants |
| Q81665403 | No evidence of existence of functional 5-HT(1) receptors in isolated and perfused canine basilar arteries |
| Q48779366 | Nomenclature and classification of transmitter receptors: an integrated approach |
| Q36660314 | Ondansetron. Therapeutic use as an antiemetic |
| Q37109520 | Ondansetron: A Serotonin Receptor (5-HT3) Antagonist for Antineoplastic Chemotherapy-Induced Nausea and Vomiting |
| Q34320153 | Ondansetron: a selective 5-HT(3) receptor antagonist and its applications in CNS-related disorders. |
| Q41910003 | Opposing roles for 5-HT1B and 5-HT3 receptors in the control of 5-HT release in rat hippocampus in vivo |
| Q33538362 | Ovarian steroids and serotonin neural function |
| Q36543489 | Partial agonism of 5-HT3 receptors: a novel approach to the symptomatic treatment of IBS-D |
| Q35873267 | Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs |
| Q28315987 | Peristalsis evoked by 5-HT and renzapride: evidence for putative 5-HT4 receptor activation |
| Q41428568 | Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia. |
| Q48963025 | Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia |
| Q41972956 | Pharmacological analysis of 5-hydroxytryptamine effects on electrically stimulated human isolated urinary bladder |
| Q39183732 | Pharmacological analysis of male rat sexual behavior |
| Q42289225 | Pharmacological and regional characterization of [3H]LY278584 binding sites in human brain |
| Q34648658 | Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity |
| Q33709238 | Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy |
| Q42242607 | Pharmacological characteristics of 5-hydroxytryptamine autoreceptors in rat brain slices incorporating the dorsal raphe or the suprachiasmatic nucleus |
| Q42565964 | Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve |
| Q42146255 | Pharmacological characterization of 5-hydroxytryptamine-induced excitation of afferent cervical vagus nerve in anaesthetized rats |
| Q41842748 | Pharmacological characterization of 5-hydroxytryptamine-induced hyperpolarization of the rat superior cervical ganglion |
| Q34427738 | Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist |
| Q35043039 | Pharmacological characterization of the 5-HT receptor-mediated contraction in the mouse isolated ileum |
| Q35884659 | Pharmacological characterization of the 5-hydroxytryptamine receptor mediating relaxation in the rat isolated ileum |
| Q41840952 | Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors |
| Q36389333 | Pharmacology of antimigraine drugs |
| Q54318787 | Phentolamine blocks presynaptic serotonin autoreceptors in rabbit and rat brain cortex. |
| Q41716161 | Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells |
| Q36495464 | Physiology and pathophysiology of colonic motor activity (1). |
| Q41348442 | Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds |
| Q39184653 | Platelets as a model for neurones? |
| Q39531601 | Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine |
| Q51555755 | Possible involvement of 5-HT and 5-HT2 receptors in acceleration of gastrointestinal transit by escin Ib in mice. |
| Q48759946 | Potential Mechanisms Involved in the Negative Coupling Between Serotonin 5-HT1AReceptors and Carbachol-Stimulated Phosphoinositide Turnover in the Rat Hippocampus |
| Q73031681 | Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration |
| Q91810699 | Potentiation of the glycine response by serotonin on the substantia gelatinosa neurons of the trigeminal subnucleus caudalis in mice |
| Q41661654 | Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine |
| Q41909062 | Presence of vasoconstrictor 5HT1-like receptors revealed by precontraction of rabbit isolated mesenteric artery |
| Q37895581 | Presynaptic serotonin receptors in the central nervous system |
| Q42258411 | Prevention by the 5-HT3 receptor antagonist, ondansetron, of morphine-dependence and tolerance in the rat. |
| Q42495046 | Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone |
| Q33267111 | Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel |
| Q69016505 | Proceedings of the British Pharmacological Society. Cambridge, 8th-10th April 1987. Abstracts |
| Q68408007 | Proceedings of the British Pharmacological Society. Liverpool, 6th-8th April, 1988. Abstracts |
| Q42561528 | Properties of 5-hydroxytryptamine3 receptor-gated currents in adult rat dorsal root ganglion neurones |
| Q41852535 | Quipazine reduces food intake in the rat by activation of 5-HT2-receptors |
| Q41853498 | Rabbit isolated renal artery contractions by some tryptamine derivatives, including 2-methyl-5-HT, are mediated by a 5-HT1-like receptor |
| Q36389341 | Rationale for the use of 5-HT1-like agonists in the treatment of migraine |
| Q40503507 | Recent advances in pediatrics |
| Q27027381 | Recent advances in the neuropsychopharmacology of serotonergic hallucinogens |
| Q43490537 | Receptors involved in the modulation of 5-hydroxytryptamine release in bovine cerebral arteries. |
| Q46751656 | Receptors mediating the contractile effect of serotonin (5-HT) in the isolated common bile duct of guinea-pig |
| Q41851750 | Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5-HT1-like or 5-HT2 receptors |
| Q42014555 | Reflex circulatory collapse following intrapulmonary entrapment of activated platelets: mediation via 5-HT3 receptor stimulation |
| Q69903712 | Reflex inhibition of efferent renal sympathetic nerve activity by 5-hydroxytryptamine and nicotine is elicited by different epicardial receptors |
| Q45783562 | Regulation of ion and water transport across the eel intestine: effects of acetylcholine and serotonin |
| Q28361207 | Responses to 5-hydroxytryptamine evoked in the hemisected spinal cord of the neonate rat |
| Q36540897 | Rethinking 5-HT1A receptors: emerging modes of inhibitory feedback of relevance to emotion-related behavior |
| Q35779340 | Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting |
| Q41970324 | Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan |
| Q43171839 | Role of 5-ht7 receptors in the long-lasting hypotensive response induced by 5-hydroxytryptamine in the rat. |
| Q67903725 | Role of presynaptic serotonergic receptors on the mechanism of action of 5-HT1A and 5-HT1B agonists on masculine sexual behaviour: physiological and pharmacological implications |
| Q73729461 | Role of serotoninergic receptors in gonadotropin secretion in male rats |
| Q49169390 | Role of the 5HT2 receptor in the effects of serotonin and ketanserin on proliferation and differentiation of embryonic chick skin |
| Q43545228 | Roles of 5-HT receptors in the release and action of secretin on pancreatic secretion in rats |
| Q46824012 | SDZ 205-557, a selective, surmountable antagonist for 5-HT4 receptors in the isolated guinea pig ileum |
| Q37912552 | Safety by design |
| Q28341362 | Selective reduction by serotonergic agents of hypertonic saline consumption in rats: evidence for possible 5-HT1C receptor mediation |
| Q38004420 | Serotonin 5-HT1D receptors |
| Q42475635 | Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions |
| Q24632508 | Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders |
| Q38004452 | Serotonin and sleep-wakefulness |
| Q36541055 | Serotonin and the Australian connection: the science and the people |
| Q33809336 | Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies |
| Q36726602 | Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology |
| Q42519755 | Serotonin neural receptors mediate motilin-induced motility in isolated, vascularly perfused canine jejunum |
| Q69723526 | Serotonin potentiates noradrenaline-induced vasoconstriction through 5-HT1-type receptors in guinea pig basilar artery |
| Q36118965 | Serotonin receptor expression along the dorsal-ventral axis of mouse hippocampus. |
| Q39556400 | Serotonin receptor subtypes and the modulation of pain transmission |
| Q48115273 | Serotonin receptor subtypes that depolarize guinea pig inferior mesenteric ganglion neurons |
| Q58915076 | Serotonin receptors in hippocampus |
| Q40478013 | Serotonin receptors: Subtypes, functional responses and therapeutic relevance |
| Q44298706 | Serotonin release and metabolism in rat cortex as studied by transcerebral dialysis |
| Q24599332 | Serotonin spillover onto the axon initial segment of motoneurons induces central fatigue by inhibiting action potential initiation |
| Q33967265 | Serotonin syndrome and other serotonergic disorders |
| Q46306822 | Serotonin via presynaptic 5-HT1 receptors attenuates synaptic transmission to immature rat motoneurons in vitro |
| Q45955083 | Serotonin-induced pulmonary responses in the perfused guinea pig lung: evidence for 5HT2 receptor-mediated pulmonary vascular and airway smooth muscle constriction. |
| Q72281602 | Single dose pharmacokinetics of sumatriptan in healthy volunteers |
| Q40086536 | Sir David Jack: an extraordinary drug discoverer and developer |
| Q49077827 | Solubilisation of the 5-hydroxytryptamine3 receptor from pooled rat cortical and hippocampal membranes |
| Q46952122 | Species differences in presynaptic serotonin autoreceptors: mainly 5-HT1B but possibly in addition 5-HT1D in the rat, 5-HT1D in the rabbit and guinea-pig brain cortex |
| Q68105493 | Stimulation of breathing movements by L-5-hydroxytryptophan in fetal sheep during normoxia and hypoxia |
| Q30382524 | Structure and function of serotonin G protein-coupled receptors. |
| Q36379637 | Structure and functional expression of cloned rat serotonin 5HT-2 receptor |
| Q67508286 | Sumatriptan contracts large coronary arteries of beagle dogs through 5-HT1-like receptors |
| Q40857948 | Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials |
| Q57025129 | Sumatriptan is a Potent Vasoconstrictor of Human Dural Arteries Via a 5-HT1-Like Receptor |
| Q43706717 | Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT(1B)/5-HT(2A) receptor antagonists |
| Q53506698 | The (suma)triptan history revisited. |
| Q34792265 | The 5-HT1-like receptor mediating the increase in canine external carotid blood flow: close resemblance to the 5-HT1D subtype |
| Q34118878 | The 5-HT1A receptor: an overview of recent advances |
| Q38004418 | The 5-HT1B receptors |
| Q33291810 | The 5-HT2 serotonin receptor gene Htr-2 is tightly linked to Es-10 on mouse chromosome 14 |
| Q35859775 | The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphine |
| Q41468931 | The 5-HT7 receptor: orphan found |
| Q59201478 | The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra |
| Q93197716 | The Effect of Granisetron on Sensory Detection and Pain Thresholds in Facial Skin of Healthy Young Males |
| Q48734047 | The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor |
| Q53868007 | The Inhibitory Effect of Trifluoromethylphenylpiperazine on [3H]Acetylcholine Release in Guinea Pig Hippocampal Synaptosomes Is Mediated by a 5-Hydroxytryptamine1Receptor Distinct from 1A, 1B, and 1C Subtypes |
| Q37123282 | The Role of Serotonin (5-HT) in Feeding Responses to Amino Acids |
| Q51453694 | The action of 5-hydroxytryptamine on normal and cystic fibrosis mouse colon: effects on secretion and intracellular calcium. |
| Q35871404 | The action of SDZ 205,557 at 5-hydroxytryptamine (5-HT3 and 5-HT4) receptors |
| Q42710910 | The agonist properties of m-chlorophenylbiguanide and 2-methyl-5-hydroxytryptamine on 5-HT3 receptors in N1E-115 neuroblastoma cells |
| Q37685759 | The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target? |
| Q38004415 | The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties. |
| Q41500995 | The characterization and classification of neurotransmitter receptors |
| Q38679223 | The classification of 5-hydroxytryptamine receptors |
| Q68063822 | The depolarizing action of 5-hydroxytryptamine on rabbit isolated preganglionic cervical sympathetic nerves |
| Q42562469 | The effects of 5-HT on articular sensory receptors in normal and arthritic rats |
| Q41858482 | The effects of SB 204070, a highly potent and selective 5-HT4 receptor antagonist, on guinea-pig distal colon. |
| Q68593431 | The effects of ageing on prejunctional 5-hydroxytryptamine receptors in the rat vas deferens |
| Q43331108 | The effects of gamma-radiation on intestinal motor activity and faecal pellet expulsion in the guinea pig. |
| Q42115014 | The effects of intraperitoneal administration of antagonists and development of morphine tolerance on the antinociception induced by stimulating the anterior pretectal nucleus of the rat. |
| Q41348684 | The effects of serotonin agonists and antagonists on the response properties of complex ganglion cells in the rabbit's retina |
| Q68053744 | The effects of serotonin drugs on horizontal and ganglion cells in the rabbit retina |
| Q46224812 | The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons |
| Q28115183 | The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor |
| Q35872320 | The guinea-pig ileum preparation as a model for 5-HT1A receptors: anomalous effects with RS-30199-193. |
| Q41983990 | The influence of 5-hydroxytryptamine agonists and antagonists on identified sympathetic preganglionic neurones in the rat, in vivo |
| Q48179601 | The modulation of excitatory amino acid responses by serotonin in the cat neocortex in vitro |
| Q33240062 | The mouse 5-HT1C receptor contains eight hydrophobic domains and is X-linked |
| Q48640463 | The peripheral nociceptive actions of intravenously administered 5-HT in the rat requires dual activation of both 5-HT2 and 5-HT3 receptor subtypes |
| Q69930304 | The pharmacological characterisation of pilocarpine-induced purposeless chewing behaviour in the rat |
| Q35888357 | The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues |
| Q34026840 | The possible role of 5-HT(1B/D) receptors in psychiatric disorders and their potential as a target for therapy |
| Q35755424 | The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist |
| Q42847952 | The properties of 5-HT3 receptors in clonal cell lines studied by patch-clamp techniques |
| Q40480633 | The role of 5-HT3 receptors in drug dependence |
| Q26801864 | The role of dopaminergic and serotonergic systems in neurodevelopmental disorders: a focus on epilepsy and seizure susceptibility |
| Q34076822 | The role of serotonin in hot flushes |
| Q40576767 | The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system |
| Q26795511 | The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memory |
| Q52210284 | The selective 5-HT3 receptor antagonist, WAY100289, enhances spatial memory in rats with ibotenate lesions of the forebrain cholinergic projection system. |
| Q48859615 | The selectivity of the channel coupled to the 5-HT3 receptor |
| Q37967091 | The serotonin 5-HT1D receptor: a progress review |
| Q40872768 | Tropisetron (ICS 205-930): a selective 5-hydroxytryptamine antagonist |
| Q40491468 | Tumour blood flow: measurement and manipulation for therapeutic gain |
| Q28368013 | Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain |
| Q48951728 | Understanding anorexia in the elderly: formulating biopsychological research strategies |
| Q35163286 | Unique ionotropic receptors for D-aspartate are a target for serotonin-induced synaptic plasticity in Aplysia californica. |
| Q33145451 | Usefulness of intravenous granisetron for prevention of neurally mediated hypotension upon head upright tilt testing |
| Q42036074 | Vascular 5-HT1-like receptors mediating vasoconstriction and vasodilatation: their characterization and distribution in the intact canine cardiovascular system |
| Q42561781 | Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype |
| Q28365866 | Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat |
| Q28354356 | Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase |
| Q68380393 | Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors |
| Q70580240 | Visualization of serotonin effects on renal vessels of rats |
| Q42562741 | Zacopride and BRL 24924 induce an increase in EEG-energy in rats |
| Q34560485 | Zacopride, a potent 5-HT3 antagonist |
| Q34560492 | Zacopride: anxiolytic profile in rodent and primate models of anxiety |
| Q48935239 | [3H] GR67330, a very high affinity ligand for 5-HT3 receptors |
| Q42114427 | [3H]-5-carboxamidotryptamine labels 5-HT1D binding sites in bovine substantia nigra |
| Q69667396 | [3H]5-HT binding in post-mortem human cerebral cortex: methodological considerations |
| Q60711583 | [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion |
| Q34373438 | [3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study |
| Q46157404 | [3H]zacopride: ligand for the identification of 5-HT3 recognition sites |
| Q72522017 | [Antiemetic treatment and chemotherapy: general review] |
| Q83944098 | [Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research] |
Search more.